Karuna Therapeutics, Inc. which can be found using ticker (KRTX) have now 20 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 334 and 193 calculating the average target price we see $273.30. Now with the previous closing price of $218.43 this now indicates there is a potential upside of 25.1%. The 50 day MA is $194.81 and the 200 day moving average is $210.55. The company has a market capitalization of 8.38B. The current share price for the company is: 223.82 USD
The potential market cap would be $10,485,967,273 based on the market consensus.
USD
The company has a dividend yield of 2.93%. Other points of data to note are a P/E ratio of -, revenue per share of 0.34 and a -21.32% return on assets.
